The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.
Edith A. Perez
No relevant relationships to disclose
E. Aubrey Thompson
No relevant relationships to disclose
S. Keith Anderson
No relevant relationships to disclose
Yan W. Asmann
No relevant relationships to disclose
Krishna R. Kalari
No relevant relationships to disclose
Jeanette Eckel-Passow
No relevant relationships to disclose
Amylou C. Dueck
No relevant relationships to disclose
Kathleen S. Tenner
No relevant relationships to disclose
Jin Jen
No relevant relationships to disclose
Jian-Bing Fan
Employment or Leadership Position - Illumina
Stock Ownership - Illumina
Xochiquetzal Geiger
No relevant relationships to disclose
Ann E. McCullough
No relevant relationships to disclose
Beiyun Chen
No relevant relationships to disclose
Michael Zschunke
No relevant relationships to disclose
Robert B. Jenkins
No relevant relationships to disclose
George W. Sledge
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose
Julie Gralow
Research Funding - Amgen; Genentech; Novartis; Roche
Monica Madden Reinholz
No relevant relationships to disclose
Karla V. Ballman
No relevant relationships to disclose